Stay updated on DCVax-L for Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.

Latest updates to the DCVax-L for Newly Diagnosed GBM Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page adds Revision: v3.4.2 and removes the funding-lapse notice along with the prior Revision: v3.4.1.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedShow glossary feature added; capitalization tweaks for update-related labels and a new revision indicator (v3.4.0) were introduced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page shows a new revision entry (v3.3.4) and removal of the previous revision (v3.3.3). Core study information remains unchanged.SummaryDifference0.0%

- Check64 days agoChange DetectedNew recruitment sites across numerous US states and international locations were added. Several existing sites were removed.SummaryDifference2%

- Check92 days agoChange DetectedThe Publications section now notes items are automatically filled from PubMed and may not be about the study, and the page revision is updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to DCVax-L for Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.